GFS Advisors, LLC
Source: SEC Form 13F · as of Mar 2026GFS Advisors, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $118.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$118.7M
| Company | Shares | Value |
|---|---|---|
| CAHCardinal Health Inc. | 275,719 | $26.6M |
| JNJJOHNSON & JOHNSON | 110,834 | $21.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 58,096 | $15.7M |
| SNYSanofi | 162,977 | $10.0M |
| TEVATeva Pharmaceutical Industries Limited | 101,080 | $9.7M |
| MRKMerck & Co., Inc. | 79,014 | $9.5M |
| GEHCGE HealthCare Technologies Inc. | 79,014 | $9.5M |
| PFEPFIZER INC | 299,716 | $8.4M |
| BIIBBIOGEN INC. | 23,915 | $1.9M |
| BMYBRISTOL MYERS SQUIBB CO | 26,975 | $1.6M |
| ARRYARRAY BIOPHARMA INC | 80,919 | $1.5M |
| MRNAModerna, Inc. | 100,000 | $1.3M |
| CRSPCRISPR Therapeutics AG | 12,500 | $427K |
| LLYELI LILLY & Co | 420 | $386K |
| ICLRICON plc | 6,700 | $323K |
| NVONovo Nordisk A/S | 7,840 | $288K |
| OSCROscar Health Inc. | 11,350 | $130K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.